Riccardo Perfetti - 04 Mar 2025 Form 4 Insider Report for Applied Therapeutics, Inc. (APLT)

Reporting relationship: Chief Medical Officer
Issuer ticker: APLT
Reported as of: 04 Mar 2025
Net transaction value: -$4,561
SEC form: 4
Accepted by SEC: 06 Mar 2025, 20:30:30 UTC
Prior SEC filing: 07 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Leslie D. Funtleyder, Attorney-in-Fact

Key filing fact

Riccardo Perfetti filed Form 4 for Applied Therapeutics, Inc. (APLT) on 06 Mar 2025.

Key facts

This page summarizes Riccardo Perfetti's Form 4 filing for Applied Therapeutics, Inc. (APLT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Mar 2025, 20:30.

Change

Previous filing in this sequence was filed on 07 Feb 2025.
Current net transaction value: -$4,561.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

APLT transaction

Common Stock

Sale

Transaction value: $4,561
Shares: -10,366
Change %: -1.2%
Price: $0.4400
Shares after: 890,409
Date: 04 Mar 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.